Abstract
Introduction: In advanced HCC the overall benefits of multi-kinase inhibitors are limited, but some patients show partial response (PR) and a few achieve complete response (CR). Bio-mathematical modeling of in-vivo cancer cell dynamics by radiomics combining digital imaging and serological biomarkers would provide a better understanding of PR/CR.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
